SCHEMBL18159548

SCHEMBL18159548

c1cc2cccc3c4cccc5c(-c6cc(-c7ccc8oc9cccc%10cccc(c%11cccc7c8%11)c%109)cc(-c7ccc8oc9cccc%10cccc(c%11cccc7c8%11)c%109)c6)ccc(oc(c1)c23)c54

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
HPGD P15428 6/20 0.38
HSD17B10 Q99714 5/20 0.38
CYP1A2 P05177 3/20 0.38
THRB P10828 1/20 0.38
AHR P35869 4/20 0.35
MAOA P21397 3/20 0.35
MAPK1 P28482 3/20 0.35
CASP1 P29466 3/20 0.35
FYN P06241 2/20 0.35
TSHR P16473 2/20 0.35
HIF1A Q16665 2/20 0.35
ERBB2 P04626 1/20 0.35
ACHE P22303 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TYMS P04818 2/20 0.34
KDM4E B2RXH2 4/20 0.34
MAPT P10636 3/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16801060 0.95 ALDH1A1 (0.36) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801277 0.91 ALDH1A1 (0.39) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801450 0.89 ALDH1A1 (0.38) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16800612 0.89 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801129 0.89 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL18159552 0.88 HPGD (0.39) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801073 0.86 ALDH1A1 (0.40) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801512 0.85 MAPT (0.44) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801456 0.85 GSTP1 (0.42) ALDH1A1HPGDHSD17B10CYP1A2THRB
SCHEMBL16801320 0.85 ALDH1A1 (0.38) ALDH1A1HPGDHSD17B10CYP1A2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
US-11917913-B2 Substituted oxepines MERCK PATENT GMBH (DE) 2024-02-27 US disclosed
US-20190280218-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2019-09-12 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed
US-20160308146-A1 SUBSTITUTED OXEPINES MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917913-B2 Substituted oxepines OXGR1, OXTR, OCIAD2 ALDH1A1 1740/4885HPGD 907/4885HSD17B10 4302/4885
US-20190280218-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 ALDH1A1 1740/4885HPGD 907/4885HSD17B10 4302/4885
US-20160308146-A1 SUBSTITUTED OXEPINES OXGR1, OXTR, OCIAD2 ALDH1A1 1740/4885HPGD 907/4885HSD17B10 4302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.